Standardized Uptake Value Illuminates Tumor Inflammation and Treatment Response

Area of Science:

• Oncology
• Nuclear Medicine
• Cancer Imaging

Background:

• Maximum standardized uptake value (SUVmax) measured by positron emission tomography (PET) imaging is a known prognostic indicator in cervical cancer.
• Previous research suggests a correlation between lower pretreatment SUVmax and improved patient outcomes.
• Tumor microenvironment characteristics, including inflammatory signaling and myeloid-derived cell infiltration, are critical in cancer progression and treatment response.

Purpose of the Study:

• To investigate the prognostic significance of pretreatment SUVmax in cervical cancer.
• To explore the relationship between low pretreatment SUVmax and specific tumor microenvironment features.
• To determine if low SUVmax can identify patients susceptible to targeted therapies.

Main Methods:

• Analysis of pretreatment PET imaging data to determine SUVmax values in cervical cancer patients.
• Correlation analysis between SUVmax levels and established prognostic factors.
• Assessment of tumor microenvironment components, such as inflammatory markers and myeloid cell infiltration, in relation to SUVmax.

Main Results:

• A low pretreatment SUVmax was significantly associated with a superior prognosis in cervical cancer.
• Lower SUVmax values correlated with reduced inflammatory signaling within the tumor microenvironment.
• Decreased infiltration of myeloid-derived cells was observed in tumors with low pretreatment SUVmax.

Conclusions:

• Pretreatment SUVmax on PET imaging is a valuable prognostic biomarker for cervical cancer.
• Low SUVmax may indicate a less inflammatory tumor microenvironment with reduced myeloid cell infiltration.
• These findings suggest that low SUVmax could identify cervical cancer patients who may benefit from targeted therapeutic strategies.